Cargando…

Heart failure prevention and monitoring strategies in HER2-positive breast cancer: a narrative review

PURPOSE: Cardiotoxicity from anti-human epidermal growth factor receptor 2 (HER2) therapy carries a short- and long-term risk of incident heart failure and increased cardiovascular mortality in patients with breast cancer. Interruptions in anti-HER2 therapy due to cardiotoxicity can lead to suboptim...

Descripción completa

Detalles Bibliográficos
Autores principales: Jafari, Lua, Akhter, Nausheen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820093/
https://www.ncbi.nlm.nih.gov/pubmed/33481134
http://dx.doi.org/10.1007/s10549-021-06096-9